PolyPid PYPD
NASDAQ PYPD
$5.19 -0.18 (-3.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

PolyPid (PYPD) Income from Non-Controlling Interests (2020)

Updated

PolyPid's Income from Non-Controlling Interests was $6.46 million in Q3 2020, down 66.2% from the prior quarter.

Analysis

PolyPid (PYPD) Income from Non-Controlling Interests (2020) Analysis & Trends

  • The Q3 2020 figure marks the lowest quarterly Income from Non-Controlling Interests since Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -2.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -7.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 10.00 Mn
10 PolyPid 94.48 Mn 45.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 6.46 Mn
Jun 30, 2020 19.11 Mn
API Access

PolyPid Income from Non-Controlling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PYPD&period=max&api_key=YOUR_API_KEY